Many men with lower life expectancy and localized prostate cancer get overtreated. Rates of definitive treatment have increased for men with intermediate-risk and high-risk disease. Perspective ...

For men with high-risk prostate cancer and a five-year life expectancy, treatment rose from 17.3% to 46.5%. The researchers concluded that “overtreatment of men with limited LE [life expectancy ...

Overtreatment of older prostate cancer patients with a limited life expectancy has increased over the past two decades among ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of ...

The city laid out a series of proposals to reduce cancer deaths by 20 percent, and deaths from heart- and diabetes-related ...

Breast cancer survivors who harbor BRCA ... More men with limited life expectancy and certain localized prostate cancers have received definitive treatment over the past 2 decades despite shifts ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

the number of prostate cancer cases worldwide could double as life expectancy for men gets longer. “We’re expecting a surge in prostate cancer cases,” he said, “So we really need new ...